BLC
BSX icon

Brown, Lisle/Cummings’s Boston Scientific BSX Stock Holding History

Brown, Lisle/Cummings’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.75M Buy
75,763
+1,320
+2% +$106K 1.19% 20
2025
Q4 		$7.1M Sell
74,443
-900
-1% -$88.2K 1.75% 10
2025
Q3 		$7.36M Sell
75,343
-225
-0.3% -$23.3K 1.89% 8
2025
Q2 		$8.12M Buy
75,568
+1,175
+2% +$119K 2.16% 7
2025
Q1 		$7.5M Sell
74,393
-132
-0.2% -$13.3K 2.18% 8
2024
Q4 		$6.66M Buy
74,525
+833
+1% +$73.3K 1.99% 8
2024
Q3 		$6.18M Buy
73,692
+75
+0.1% +$5.91K 1.88% 9
2024
Q2 		$5.67M Buy
73,617
+250
+0.3% +$18.3K 1.85% 10
2024
Q1 		$5.02M Buy
73,367
+1,250
+2% +$80.4K 1.71% 11
2023
Q4 		$4.17M Sell
72,117
-100
-0.1% -$5.34K 1.55% 11
2023
Q3 		$3.81M Buy
72,217
+2,525
+4% +$132K 1.73% 12
2023
Q2 		$3.77M Buy
69,692
+6,625
+11% +$346K 1.69% 13
2023
Q1 		$3.16M Buy
63,067
+975
+2% +$46K 1.6% 14
2022
Q4 		$2.87M Buy
62,092
+1,275
+2% +$55.2K 1.54% 13
2022
Q3 		$2.36M Sell
60,817
-1,000
-2% -$40.1K 1.38% 17
2022
Q2 		$2.3M Buy
61,817
+2,475
+4% +$101K 1.28% 20
2022
Q1 		$2.63M Buy
59,342
+5,225
+10% +$226K 1.26% 20
2021
Q4 		$2.3M Buy
+54,117
New +$2.27M 1.15% 20

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brown, Lisle/Cummings's BSX Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Boston Scientific (BSX) stake by 1.8% in Q1 2026, buying an estimated $106K and bringing the position to 75,763 shares worth $4.75M. The position accounts for 1.19% of the portfolio, ranked #20.

Brown, Lisle/Cummings first reported a position in BSX in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.12M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Brown, Lisle/Cummings held 75,763 shares of Boston Scientific worth $4.75M as of Q1 2026.
  • Brown, Lisle/Cummings bought 1,320 Boston Scientific shares in Q1 2026, an estimated $106K.
  • Boston Scientific made up 1.19% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #20 holding.
  • Brown, Lisle/Cummings first reported a position in Boston Scientific in Q4 2021 and has held it in 18 quarters since.
  • Brown, Lisle/Cummings's Boston Scientific position peaked at $8.12M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.